CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that ...

CHICAGO, October 15, 2024--MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics ...

Annual Biotechnology, Systems, and Synthetic Biology Poster Fair: This event will be held in the Spring Quarter at a venue located at the Chicago campus, at which students and postdocs will have the ...

PanGIA Biotech Announces Upcoming ASCO 2025 Poster Presentation of Collaborative Research. PanGIA Biotech, a company advancing urine-based, AI-driven diagnostics for early cancer detection, today ...

MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025. ... from our research and data to our policies on content and your personal data. We’d ...

MAIA Biotechnology, Inc.,, a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that a late-breaking abstract detailing new updates from its ...

MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract ...

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics Contacts Investor Relations Contact +1 (872) 270-3518 ir ...

PanGIA Biotech, a company advancing urine-based, AI-driven diagnostics for early cancer detection, today announced that an abstract co-authored by researchers from PanGIA Biotech, Entopsis Inc ...

MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025 Mar. 25, 2025 8:46 AM ET MAIA Biotechnology, Inc. (MAIA) Q4: 2025-03-21 Earnings Summary ...

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics Oct. 15, 2024 8:15 AM ET MAIA Biotechnology, Inc. (MAIA) ...